Compound Evidence File
#EC-2026-0805
GHK-Cu
Filed under Peptides. The bureau holds 414 laboratory returns for this compound from 74 distinct subjects. Scores below are per-subject aggregates; open a subject row for the underlying evidence.
Cross-Index
Subjects Shipping This Compound
74 SUBJECTS| Subject | Grade | Samples | Mean | Min | Max | First seen | Last seen |
|---|---|---|---|---|---|---|---|
| Tianjin Finder Chemical TFCCASE #VI-2026-0693 | A | 8 | 10.0 | 9.9 | 10.0 | 14 Nov 2025 | 16 Apr 2026 |
| Shanghai ERP BiotechnologyCASE #VI-2026-0936 | A | 4 | 10.0 | 9.9 | 10.0 | 15 Jan 2026 | 10 Mar 2026 |
| Mokemei BiotechnologyCASE #VI-2026-0540 | A | 4 | 10.0 | 10.0 | 10.0 | 25 Nov 2025 | 26 Jun 2026 |
| PolyPeptide GroupCASE #VI-2026-0143 | A | 4 | 10.0 | 9.9 | 10.0 | 13 Mar 2026 | 15 Aug 2026 |
| SinoPepCASE #VI-2026-0387 | A | 4 | 10.0 | 10.0 | 10.0 | 28 Apr 2026 | 27 Jun 2026 |
| AsymchemCASE #VI-2026-0091 | A | 4 | 10.0 | 9.9 | 10.0 | 2 Mar 2026 | 4 Aug 2026 |
| Sangon BioCASE #VI-2026-0671 | A | 3 | 10.0 | 9.9 | 10.0 | 25 Dec 2025 | 6 Jun 2026 |
| BachemCASE #VI-2026-0314 | A | 3 | 10.0 | 9.9 | 10.0 | 13 Mar 2026 | 13 Jun 2026 |
| Hubei JianxiangCASE #VI-2026-0048 | A | 3 | 10.0 | 10.0 | 10.0 | 22 Jan 2026 | 25 May 2026 |
| WuXi TIDESCASE #VI-2026-0335 | A | 3 | 10.0 | 9.9 | 10.0 | 26 Mar 2026 | 3 Jun 2026 |
| Pharma Grade PeptidesCASE #VI-2026-0208 | A | 2 | 10.0 | 10.0 | 10.0 | 6 May 2025 | 6 May 2025 |
| HomopeptideCASE #VI-2026-0760 | A | 4 | 9.9 | 9.9 | 10.0 | 24 May 2026 | 24 May 2026 |
| QYAOBIOCASE #VI-2026-0861 | A | 4 | 9.9 | 9.9 | 10.0 | 4 Apr 2026 | 20 Jun 2026 |
| JEEP PeptidesCASE #VI-2026-0457 | A | 4 | 9.9 | 9.9 | 10.0 | 15 Dec 2025 | 27 Jun 2026 |
| Chinese Peptide CompanyCASE #VI-2026-0184 | A | 4 | 9.9 | 9.9 | 10.0 | 22 Dec 2025 | 21 Jun 2026 |
| Shanghai Sigma AudleyCASE #VI-2026-0505 | A | 4 | 9.9 | 9.9 | 10.0 | 21 Feb 2026 | 12 Jul 2026 |
| Hybio PharmaceuticalCASE #VI-2026-0065 | A | 4 | 9.9 | 9.9 | 10.0 | 16 Jan 2026 | 26 Apr 2026 |
| AmbioPharmCASE #VI-2026-0177 | A | 4 | 9.9 | 9.9 | 10.0 | 6 Jun 2026 | 13 Aug 2026 |
| Shanghai Wibson BiotechnologyCASE #VI-2026-0379 | A | 3 | 9.9 | 9.9 | 10.0 | 11 Apr 2026 | 14 Jul 2026 |
| Kerui PeptidesCASE #VI-2026-0626 | A | 2 | 9.9 | 9.9 | 9.9 | 20 Jan 2026 | 20 Apr 2026 |
| Flourishglobal PeptideCASE #VI-2026-0630 | A | 2 | 9.9 | 9.9 | 9.9 | 22 Apr 2026 | 8 May 2026 |
| GenScript PeptidesCASE #VI-2026-0860 | A | 2 | 9.9 | 9.9 | 10.0 | 5 Feb 2026 | 20 Jul 2026 |
| Sigma-AldrichCASE #VI-2026-0829 | A | 2 | 9.9 | 9.9 | 10.0 | 19 Jan 2026 | 11 Mar 2026 |
| Thermo Fisher ScientificCASE #VI-2026-0142 | A | 2 | 9.9 | 9.9 | 10.0 | 12 Dec 2025 | 11 Jul 2026 |
| Nanjing Xiyuxun Technology XYXCASE #VI-2026-0433 | X | 1 | 9.8 | 9.8 | 9.8 | 16 Jul 2025 | 16 Jul 2025 |
| Qingdao Sigma Chemical QSCCASE #VI-2026-0538 | A | 3 | 9.3 | 9.0 | 9.6 | 21 May 2026 | 21 May 2026 |
| SubQ SocietyCASE #VI-2026-0716 | X | 1 | 9.3 | 9.3 | 9.3 | 25 May 2026 | 25 May 2026 |
| Bulk Peptide WholesaleCASE #VI-2026-0319 | A | 3 | 9.2 | 8.3 | 10.0 | 6 Dec 2025 | 19 May 2026 |
| Orbitrex PeptidesCASE #VI-2026-0812 | A | 2 | 9.1 | 9.0 | 9.2 | 25 Oct 2025 | 27 Oct 2025 |
| Shanghai Sigma Audley SSACASE #VI-2026-0486 | A | 7 | 8.9 | 8.1 | 10.0 | 24 May 2026 | 24 May 2026 |
| Atomik LabzCASE #VI-2026-0327 | A | 4 | 8.7 | 7.6 | 9.8 | 6 May 2025 | 20 May 2025 |
| Yabang PeptideCASE #VI-2026-0148 | X | 1 | 8.7 | 8.7 | 8.7 | 25 May 2026 | 25 May 2026 |
| Glbiochem (Shanghai)CASE #VI-2026-0704 | A | 8 | 8.5 | 7.9 | 9.7 | 25 May 2026 | 25 May 2026 |
| Heman Peptide HMCASE #VI-2026-0089 | A | 4 | 8.4 | 7.8 | 10.0 | 23 Oct 2025 | 29 Dec 2025 |
| Nantong Guangyuan Chemical GYCCASE #VI-2026-0284 | A | 3 | 8.3 | 7.4 | 9.8 | 25 May 2026 | 25 May 2026 |
| Wuhan Wansheng Bio (WWB)CASE #VI-2026-0594 | A | 7 | 8.1 | 7.3 | 9.0 | 24 May 2026 | 24 May 2026 |
| Peptide SciencesCASE #VI-2026-0867 | B | 6 | 8.1 | 5.6 | 9.8 | 6 May 2025 | 23 May 2026 |
| Precision Peptide CoCASE #VI-2026-0559 | A | 4 | 8.0 | 6.9 | 9.0 | 6 May 2025 | 10 Jul 2025 |
| Polaris PeptidesCASE #VI-2026-0839 | A | 3 | 8.0 | 6.5 | 9.0 | 6 Aug 2025 | 25 Nov 2025 |
| Qing Li PeptideCASE #VI-2026-0469 | C | 27 | 8.0 | 4.7 | 10.0 | 10 Jul 2025 | 24 May 2026 |
| Yiwu Aozuo Trading CoCASE #VI-2026-0798 | C | 9 | 7.8 | 4.9 | 9.9 | 4 Sep 2025 | 25 May 2026 |
| Peptide-SCASE #VI-2026-0111 | C | 8 | 7.8 | 5.0 | 10.0 | 16 Jul 2025 | 22 May 2026 |
| Zen PeptidesCASE #VI-2026-0940 | B | 4 | 7.7 | 5.2 | 9.5 | 23 Oct 2025 | 17 Dec 2025 |
| Xingruida XDRCASE #VI-2026-0898 | C | 8 | 7.6 | 4.7 | 10.0 | 25 Nov 2025 | 19 May 2026 |
| Reta-PeptideCASE #VI-2026-0756 | C | 18 | 7.5 | 4.7 | 10.0 | 16 Jul 2025 | 24 May 2026 |
| PeptidologyCASE #VI-2026-0520 | A | 6 | 7.4 | 6.2 | 9.0 | 14 Jun 2025 | 11 Aug 2025 |
| Tianjin Ruiwang New Material Technology CoCASE #VI-2026-0192 | C | 12 | 7.3 | 4.5 | 8.0 | 3 Oct 2025 | 19 May 2026 |
| UtherCASE #VI-2026-0902 | C | 6 | 7.3 | 4.2 | 9.5 | 9 Oct 2025 | 24 May 2026 |
| Biolongevity LabsCASE #VI-2026-0442 | A | 4 | 7.2 | 6.8 | 7.9 | 14 Jun 2025 | 6 Dec 2025 |
| ScienceCASE #VI-2026-0636 | A | 4 | 7.2 | 6.5 | 7.6 | 20 May 2025 | 10 Jul 2025 |
| Nuscience PeptidesCASE #VI-2026-0554 | A | 2 | 7.2 | 7.2 | 7.2 | 6 May 2025 | 6 May 2025 |
| Accelerate LabsCASE #VI-2026-0686 | A | 2 | 7.2 | 7.2 | 7.2 | 10 Jul 2025 | 10 Jul 2025 |
| LSPLCASE #VI-2026-0523 | C | 6 | 7.1 | 4.7 | 9.4 | 6 Nov 2025 | 22 May 2026 |
| Xian Yihang TechnologyCASE #VI-2026-0656 | C | 6 | 7.1 | 4.0 | 8.0 | 10 Jul 2025 | 20 May 2026 |
| YimeiCASE #VI-2026-0081 | B | 13 | 7.0 | 5.0 | 8.0 | 25 Nov 2025 | 24 May 2026 |
| OupeptideCASE #VI-2026-0435 | B | 8 | 7.0 | 5.6 | 8.0 | 14 Aug 2025 | 21 May 2026 |
| Mai PeptideCASE #VI-2026-0769 | C | 8 | 7.0 | 4.7 | 10.0 | 17 Dec 2025 | 22 May 2026 |
| Shanxi Qianyecao Biotech QYCCASE #VI-2026-0189 | E | 8 | 6.9 | 2.8 | 8.0 | 25 Sep 2025 | 22 May 2026 |
| HXNetCASE #VI-2026-0061 | C | 10 | 6.8 | 4.7 | 10.0 | 17 Nov 2025 | 21 May 2026 |
| ZLZ PeptideCASE #VI-2026-0524 | C | 9 | 6.7 | 4.5 | 8.0 | 4 Aug 2025 | 19 Jan 2026 |
| HK PeptidesCASE #VI-2026-0140 | E | 34 | 6.7 | 2.0 | 10.0 | 16 Jul 2025 | 23 May 2026 |
| NexaphCASE #VI-2026-0944 | C | 5 | 6.6 | 4.3 | 8.2 | 4 Aug 2025 | 17 May 2026 |
| LiliPeptideCASE #VI-2026-0695 | C | 17 | 6.4 | 4.6 | 8.0 | 25 Sep 2025 | 24 May 2026 |
| TSC Top Supplements ChinaCASE #VI-2026-0523 | C | 8 | 6.3 | 4.8 | 8.0 | 4 Sep 2025 | 4 Nov 2025 |
| PeptiLab ResearchCASE #VI-2026-0267 | C | 3 | 5.9 | 4.8 | 7.8 | 25 Apr 2025 | 6 May 2025 |
| Zhejiang Yichenkang BiotechnologyCASE #VI-2026-0269 | C | 4 | 5.5 | 4.8 | 6.8 | 10 Jul 2025 | 20 Sep 2025 |
| Planet PeptideCASE #VI-2026-0092 | X | 1 | 5.5 | 5.5 | 5.5 | 20 May 2025 | 20 May 2025 |
| Prime PeptidesCASE #VI-2026-0696 | C | 5 | 5.1 | 4.7 | 5.5 | 20 May 2025 | 10 Jul 2025 |
| Peptides 4 ResearchCASE #VI-2026-0511 | C | 4 | 5.0 | 4.8 | 5.2 | 6 May 2025 | 20 May 2025 |
| Suaway Lab ResearchCASE #VI-2026-0488 | D | 5 | 4.9 | 4.6 | 5.4 | 22 Apr 2025 | 10 Jul 2025 |
| SRY LabsCASE #VI-2026-0657 | E | 7 | 4.9 | 2.6 | 8.0 | 10 Sep 2025 | 17 May 2026 |
| Peptide ArkCASE #VI-2026-0350 | X | 1 | 4.9 | 4.9 | 4.9 | 24 May 2026 | 24 May 2026 |
| Wuhan Newtop BiotechCASE #VI-2026-0676 | X | 1 | 4.1 | 4.1 | 4.1 | 25 May 2026 | 25 May 2026 |
| Explicit SarmsCASE #VI-2026-0017 | X | 1 | 3.7 | 3.7 | 3.7 | 25 May 2026 | 25 May 2026 |
Open any subject to view the batch-level evidence for GHK-Cu alone.